Bayesian Capital Management’s argenx ARGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-2,920
Closed -$2.15M 143
2025
Q3
$2.15M Buy
+2,920
New +$1.93M 0.44% 61
2025
Q2
Sell
-761
Closed -$450K 542
2025
Q1
$450K Buy
761
+140
+23% +$88.4K 0.07% 320
2024
Q4
$382K Buy
621
+171
+38% +$100K 0.05% 435
2024
Q3
$244K Buy
+450
New +$227K 0.03% 523
2024
Q1
Sell
-2,385
Closed -$907K 771
2023
Q4
$907K Buy
2,385
+1,300
+120% +$606K 0.1% 251
2023
Q3
$533K Buy
+1,085
New +$531K 0.06% 360
2023
Q2
Sell
-4,607
Closed -$1.72M 783
2023
Q1
$1.72M Sell
4,607
-400
-8% -$148K 0.21% 136
2022
Q4
$1.9M Buy
5,007
+3,811
+319% +$1.43M 0.28% 69
2022
Q3
$422K Buy
+1,196
New +$443K 0.09% 326
2020
Q1
Sell
-1,501
Closed -$241K 771
2019
Q4
$241K Buy
+1,501
New +$203K 0.04% 485

Other funds holding ARGX

Bayesian Capital Management's ARGX Position: Q4 2025 in Review

Bayesian Capital Management sold out of argenx (ARGX) in Q4 2025, closing a stake of 2,920 shares — an estimated $2.15M sold.

Bayesian Capital Management first reported a position in ARGX in Q4 2019 and held it in 10 quarters. The position peaked at $2.15M in Q3 2025. 507 funds tracked by Wall St. Rank hold ARGX as of Q4 2025.

  • Bayesian Capital Management reported no remaining argenx position as of Q4 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 2,920 argenx shares in Q4 2025, an estimated $2.15M.
  • Bayesian Capital Management first reported a position in argenx in Q4 2019 and held it in 10 quarters.
  • Bayesian Capital Management's argenx position peaked at $2.15M in Q3 2025.
  • 507 funds tracked by Wall St. Rank held argenx as of Q4 2025.

Based on Bayesian Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.